TP53 and cancer: In a study by He et al., 2016, six gene mutations in cfDNA were shared between healthy controls and NSCLC patients, however, mutations in TP53 as well as in other genes were exclusively found in cancer patients [26], suggesting the mutation pattern may differ between cancer-affected and cancer-free individuals.